Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
$HIMS growth slowdown ahead

$HIMS growth slowdown ahead

TradingViewTradingView2026/03/07 09:12
By:TradingView
- HIMS is quite overvalued. There's no moat to a business model.
- They got a good branding that's all. There are 10-15 other startups selling the same things under different umbrella.
- They even stole NVO flagship weight loss drugs. These cheap alternatives will risk lives of people and will open plethora of lawsuits.
- Growth is slowing down to low 20s which calls for correction in the multiple.

- Anyone paying more than 20x will likely suffer from massive losses within an year timeframe.

- Fundamentally,

Year | 2025 | 2026 | 2027 | 2028
EPS | 0.57 | 0.79 | 1.05 | 1.40
EPS% | 5.76% | 38.31% | 32.59% | 33.25%

Giving benefit of doubt and being generous, 30x multiple as a base case. Fair stock value:
Year | 2025 | 2026 | 2027 | 2028
Price | $17 | $23 | $31 | $42

- We should visit the $23-26 range somewhere in 2026
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!